dichloroacetic acid has been researched along with Carcinoma, Hepatocellular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, Y; Choi, DH; Kim, SY; Kim, TS; Lee, CY; Lee, M; Park, M; Shim, MS | 1 |
| Chen, A; Dong, J; Li, B; Meng, G; Wei, J; Wu, J; Xu, T; Yu, D; Zhang, H; Zheng, M | 1 |
| Dai, Y; Huang, G; Liu, J; Qin, W; Sheng, S; Wang, H; Xiong, X | 1 |
| Boorman, GA; Hejtmancik, MR; Herbert, RA; Johnson, JD; Kissling, GE; Malarkey, DE; Vallant, MK | 1 |
| DeAngelo, AB; George, MH; House, DE | 1 |
5 other study(ies) available for dichloroacetic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
Topics: Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Phosphatidylinositol 3-Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Transcription Factors | 2021 |
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dichloroacetic Acid; Glycolysis; Humans; Immunotherapy; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Newcastle disease virus; Oncolytic Virotherapy; Oncolytic Viruses; Oxygen; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Transfection; Tumor Burden; Virus Replication; Xenograft Model Antitumor Assays | 2020 |
Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels.
Topics: Acetylcysteine; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Doxorubicin; Humans; Liver Neoplasms; Male; Mice; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2014 |
Evaluation of dichloroacetic acid for carcinogenicity in genetically modified Tg.AC hemizygous and p53 haploinsufficient mice.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Carcinogenicity Tests; Carcinoma, Hepatocellular; Dichloroacetic Acid; Disease Models, Animal; Female; Liver Neoplasms; Male; Mice; Mice, Transgenic; Neoplasms; Papilloma; Skin Neoplasms; Vacuoles; Water; Water Supply | 2009 |
Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action.
Topics: Analysis of Variance; Animals; Body Weight; Carcinogens; Carcinoma, Hepatocellular; Dichloroacetic Acid; Dose-Response Relationship, Drug; Kidney; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Organ Size; Specific Pathogen-Free Organisms; Spleen; Survival Analysis; Testis; Time Factors; Water Pollutants | 1999 |